I think a reverse split is a possibility, especially after the announcement couldn't move the PPS. If that happens, will likely add fuel to any downward price pressure. Management don't seem the best. Now it's do or die with the in vivo programs.
Recent DTIL News
- Precision BioSciences to Report Third Quarter Results on November 4, 2024 • Business Wire • 10/29/2024 11:01:00 AM
- Precision BioSciences to Host Virtual Investor Event Highlighting PBGENE-HBV Preclinical Safety Data and Phase 1 Clinical Trial Plans on November 15, 2024 • Business Wire • 10/28/2024 11:01:00 AM
- Precision BioSciences Presents Preclinical Data Highlighting the Capability of ARCUS for High-Efficiency Gene Editing Utilizing Homology-Directed Repair at the ESGCT 31st Annual Congress • Business Wire • 10/24/2024 08:15:00 PM
- Precision BioSciences Receives First Approval of Clinical Trial Application to Initiate PBGENE-HBV First-In-Human Study for the Treatment of Chronic Hepatitis B • Business Wire • 10/24/2024 12:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 12:45:07 PM
- Precision BioSciences to Participate in Upcoming Longwood Boston CEO and Guggenheim Healthcare Conferences • Business Wire • 10/21/2024 11:01:00 AM
- Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Congress • Business Wire • 10/16/2024 11:01:00 AM
- Precision BioSciences to Present at the Upcoming H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference • Business Wire • 10/03/2024 11:01:00 AM
- Precision BioSciences Submits First Clinical Trial Applications to Initiate Phase 1 Trial for PBGENE-HBV for the Treatment of Chronic Hepatitis B • Business Wire • 09/30/2024 11:01:00 AM
- Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/20/2024 11:01:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 12:00:13 PM
- Precision BioSciences Strengthens Senior Leadership Team Ahead of Anticipated PBGENE-HBV Clinical Execution • Business Wire • 09/12/2024 11:15:00 AM
- Precision BioSciences to Participate in Upcoming H.C. Wainwright 26th Annual Global Healthcare Conference • Business Wire • 09/04/2024 11:01:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 12:03:28 PM
- Precision BioSciences Receives $13 Million in Proceeds from Imugene Convertible Note Maturity as Part of the August 2023 Azer-cel Deal • Business Wire • 09/03/2024 11:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 11:30:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 11:30:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 11:30:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 11:30:02 AM
- Precision BioSciences Announces Investigational New Drug Clearance by Partner TG Therapeutics for Investigation of Azer-Cel for Multiple Sclerosis • Business Wire • 08/09/2024 11:01:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 11:30:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:30:08 AM
- Precision BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update • Business Wire • 08/01/2024 11:15:00 AM
- Precision BioSciences to Participate in Upcoming August Investor Conferences • Business Wire • 07/31/2024 11:01:00 AM
- Precision BioSciences to Report Second Quarter Results on August 1, 2024 • Business Wire • 07/29/2024 08:15:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM